MANNKIND CORP Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2021-11-09: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2021-08-11: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2021-05-12: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2021-02-25: Form 10-K; Item Smaller reporting company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2021-11-09 | 10-Q | Smaller reporting company | Yes |
| 2021-08-11 | 10-Q | Smaller reporting company | Yes |
| 2021-05-12 | 10-Q | Smaller reporting company | Yes |
| 2021-02-25 | 10-K | Smaller reporting company | Yes |
| 2021-02-25 | 10-K | Well-known seasoned issuer | No |
| 2020-11-04 | 10-Q | Smaller reporting company | Yes |
| 2020-08-05 | 10-Q | Smaller reporting company | Yes |
| 2020-05-06 | 10-Q | Smaller reporting company | Yes |
| 2020-02-25 | 10-K | Smaller reporting company | Yes |
| 2020-02-25 | 10-K | Well-known seasoned issuer | No |
| 2019-11-08 | 10-Q | Smaller reporting company | Yes |
| 2019-08-07 | 10-Q | Smaller reporting company | Yes |
| 2019-02-26 | 10-K | Well-known seasoned issuer | No |
| 2018-02-27 | 10-K | Well-known seasoned issuer | No |
| 2017-03-16 | 10-K | Well-known seasoned issuer | No |
| 2016-03-15 | 10-K | Well-known seasoned issuer | No |
| 2013-03-18 | 10-K | Well-known seasoned issuer | No |
| 2012-03-15 | 10-K | Well-known seasoned issuer | No |
| 2011-11-04 | 10-Q | Well-known seasoned issuer | No |
| 2011-08-04 | 10-Q | Well-known seasoned issuer | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |